To our knowledge, this is the first example of the involvement of ULK1 signalling in the regulation of STAT3‐dependent autophagy/apoptosis and highlight the targeting of both STAT3 and ULK1 as a potential novel therapeutic approach for GBM treatment. This evidence concerns the gene STAT3 and glioblastoma.